Clinical trial
Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal…
NCT00127855 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00127855 |
|---|---|
| Title | Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine |
| Official title | A Phase II, Open (Partially Double-blind), Randomised, Controlled, Multicentre, Primary Vaccination Study to Evaluate the Immunogenicity (Including Immune Memory), Reactogenicity and Safety of Three Different Formulations of the GSK Biologicals' Combined Haemophilus Influenzae Type B-meningococcal… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Haemophilus Influenzae Type b, Neisseria Meningitidis |
| Intervention type | Biological |
| Interventions | Hib-MenCY-TT vaccine (MenHibrix), Meningitec®, ActHIB®, Infanrix® Penta, Prevenar®, Mencevax® ACWY, PRP (Polyribosyl Ribitol Phosphate) |
| Enrollment | 409 |
| Start date | Mar 1, 2003 |
| Primary completion | Feb 1, 2004 |
| Completion | Feb 12, 2004 |
| First posted | Aug 9, 2005 |
| Last update posted | Aug 27, 2018 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: